$6---------------->$21.43 Yikes I didn't realize hoe long ago I profiled this for you What a call!!!
Unfortunately we in much later.
Y-mAbs up 17% after hours on strong 2024 guidance, quarterly beats
YMAB Y-mAbs Therapeutics, Inc.
$16.700.37(+2.27%)4:00 PM 02/29/24
NASDAQ |$USD...